LifeStance Health appoints Sarah Personette to board of directors
Get Alerts LFST Hot Sheet
Join SI Premium – FREE
LifeStance Health (NASDAQ: LFST) appointed Sarah Personette to its board of directors, effective immediately, according to a company statement. William Miller, WellSky Chairman and CEO, will step down from the board after five years of service.
Personette currently serves as CEO of Puck, a journalist-owned media platform. She previously held the position of Chief Customer Officer at social platform X, formerly known as Twitter, where she oversaw global revenue, customer relationships and business operations. Before joining X, she served as Chief Operating Officer of Refinery29, managing the company's marketing and sales efforts.
Earlier in her career, Personette worked as Vice President of Facebook's Global Business Marketing, leading a 500-person team responsible for promoting Facebook's advertising products. She also held senior positions at advertising agencies Universal McCann Worldwide and Starcom Mediavest Group.
"Sarah's longstanding focus on understanding consumer behavior to improve the customer experience parallels our commitment to delivering patient-centered care," said Dave Bourdon, CEO of LifeStance Health.
LifeStance Health describes itself as one of the nation's largest providers of outpatient mental health care. The company was founded in 2017 and employs approximately 7,700 psychiatrists, advanced practice nurses, psychologists and therapists across 33 states and more than 550 centers.
The company provides virtual and in-person mental health services for children, adolescents and adults. LifeStance Health trades on the NASDAQ under the ticker symbol LFST.
You May Also Be Interested In
- Atmos Energy adds law partner James Jeffries to its board
- ADM board director Lei Z. Schlitz to resign at year-end
- ManpowerGroup adds Paychex CEO John Gibson to its board
Create E-mail Alert Related Categories
Board ChangesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share